Latest Bone marrow Stories
'Novel' Reality Program Aims to Boost Breast Cancer, Leukemia Awareness ...
High value auction items for bidding until April 20 at charitybuzz to benefit Bone Marrow Foundation Be A Lifeline (TM) NEW YORK, April 12, 2011 /PRNewswire-USNewswire/ -- Be a lifeline for patients with life threatening cancer and genetic blood disorders while delighting in the talents of celebrity designer Charlotte Moss, New York City Ballet's former Principal Dancer Darci Kistler, or designer Meg Braff by winning their personalized auction packages in the Bone Marrow Foundation auction at...
An experimental drug lessens symptoms of a rare form of childhood leukemia and offers significant insight into the cellular development of the disease, according to findings from a new UCSF study.
An experimental drug lessens symptoms of a rare form of childhood leukemia and offers significant insight into the cellular development of the disease.
A NASA technology originally developed for plant growth experiments on space shuttle missions has successfully reduced the painful side effects resulting from chemotherapy and radiation treatment in bone marrow and stem cell transplant patients.
A long term study reports about the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous (self) stem cell rescue for people with aggressive forms of multiple sclerosis (MS).
Last year 137,000 adults and children in the United States were diagnosed with leukemia, lymphoma and myeloma, accounting for 9 percent of the 1.5 million cancer diagnoses made overall in 2010.
Researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue and improved function to injured heart areas.
Stem cells derived from a patientâ€™s own bone marrow were safely used in pediatric patients with traumatic brain injury (TBI).
When patients receive a bone marrow transplant, they are getting a new population of hematopoietic stem cells.
Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.